JBM Healthcare acquires Target Group for HK$38m

JBM Healthcare (HKEX: 2161) announced the acquisition of Target Group, a Hong Kong-based company specializing in Chinese medicine consultancy and health product sales. The deal, formalized through a Sale and Purchase Agreement (SPA) dated June 16, 2025, involves JBM Healthcare acquiring the entire issued share capital of Target Group for a total consideration of HK$38 million, subject to potential adjustments. The acquisition is expected to boost JBM Healthcare's access to a well-established customer base and broaden its product portfolio within the traditional Chinese medicine sector. The consideration will be paid in installments, with HK$22.8 million upfront, HK$7.6 million at completion, and a HK$7.6 million Retained Payment contingent on the Target Group's 2025 financial performance.